For decades, high-resolution protein structure determination relied heavily on techniques such as X-ray crystallography and NMR spectroscopy.

Developing a new obesity drug requires multiple steps: target validation, pharmacokinetic studies, safety assessments, and more. Protheragen Obesity is a Contract Research Organization (CRO) that provides exactly these services, with a focus on the preclinical stage.